Theodosios D. Filippatos

Author

Also Known As

T D Filippatos, T Filippatos, T. D. Filippatos, T. D. Filippatosm, T. Filippatos, T.D. Filippatos, TD Filippatos, THEODOSIOS D FILIPPATOS, Td Filippatos, Theodosios D Filippatos

194

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

University of Ioannina University College London The Royal Free Hospital University Hospital of Ioannina University of Crete

About

Theodosios D. Filippatos is an author at University of Ioannina specializing in medicine, metabolic syndrome, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	919
2	Health Sciences	8	8	450
3	Public Health	8	8	234
4	Biochemistry	3	3	121
5	Anesthesia	1	1	19

Theodosios D. Filippatos

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma Irene F. Gazi, E. Lourida, Theodosios D. Filippatos, Clinical Chemistry	2005	162
Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome Theodosios D. Filippatos, Christos S. Derdemezis, Dimitrios N. Kiortsis, Journal of Endocrinological Investigation ObesityMetabolic SyndromeOverweight PatientsMetabolic DisorderPlasma Levels	2007	118
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia M. Kalogirou, Vasilis Tsimihodimos, Irene F. Gazi, Current Medical Research and Opinion	2007	103
Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. Dimitrios N. Kiortsis, Anastasios Mavridis, Theodosios D. Filippatos, PubMed	2006	99
Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study Theodosios D. Filippatos, Dimitrios N. Kiortsis, Evangelos Liberopoulos, Current Medical Research and Opinion	2005	87
Increased plasma visfatin levels in subjects with the metabolic syndrome Theodosios D. Filippatos, Christos S. Derdemezis, I.F. Gazi, European Journal of Clinical Investigation ObesityMetabolic SyndromeBody CompositionMetabolic DisorderCardiovascular Disease	2007	83
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome Theodosios D. Filippatos, I.F. Gazi, Evangelos Liberopoulos, Atherosclerosis ObesityMetabolic SyndromeSmall Dense LdlLipoprotein-associated Phospholipase A2Biochemistry	2006	82
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria Irene F. Gazi, Vasilis Tsimihodimos, Theodosios D. Filippatos, Metabolism ObesityMetabolic SyndromeRelative DistributionLipid DisorderMetabolic Disorder	2006	75
Treating to target patients with primary hyperlipidaemia:comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study) Haralampos J. Milionis, Evangelos C. Rizos, Michael S. Kostapanos, Current Medical Research and Opinion	2006	75
Alterations in the High Density Lipoprotein Phenotype and HDL‐Associated Enzymes in Subjects with Metabolic Syndrome Konstantinos Lagos, Theodosios D. Filippatos, Vasilis Tsimihodimos, Lipids	2008	73

Page 1